To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZFHX3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
235 supporting clones for gene ZFHX3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
L32832 lung .a 1 to 11893 1 to 11893 S72A P422A A579T S767I V777A ... tiling clone,   11893/11893
(100 %)
17 diff
(99.9 %id)
NM_006885.3   .a 1 to 16064 1 to 16064 exact RefSeq,   16064/16064
(100 %)
0 diff
(100 %id)
BE836438 prostate_normal .a 1694 to 2012 1 to 318       318/326
(97 %)
9 diff
(97.3 %id)
BG774158 choriocarcinoma, placenta .a 1804 to 2378 1 to 574       574/574
(100 %)
5 diff
(99.2 %id)
DA409468 thalamus .a 1864 to 2430 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
AW887605 ovary .a 2044 to 2370 10 to 337       328/342
(95 %)
9 diff
(97.4 %id)
BM931292 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2373 to 2749 1 to 377   tiling clone, fully sequenced,   377/377
(100 %)
1 diff
(99.8 %id)
BP240071 Liver .a 2654 to 3217 1 to 564   tiling clone,   564/565
(99 %)
9 diff
(98.5 %id)
BM684861 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2719 to 3213 518 to 24   tiling clone, fully sequenced,   495/518
(95 %)
11 diff
(97.9 %id)
BC029653 Cervix, carcinoma .a 3024 to 6080 1 to 3057   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3057/3151
(97 %)
9 diff
(99.8 %id)
BI224235 cervical carcinoma cell line, cervix .a 3025 to 3833 1 to 820   available from MGC,   820/821
(99 %)
26 diff
(96.9 %id)
DA435456 tongue, tumor tissue .a 3261 to 3837 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
NM_001164766.1   .a 3393 to 16064 107 to 12778   RefSeq,   12673/12778
(99 %)
6 diff
(100.0 %id)
TI_1948087543   .a 3415 to 4125 134 to 845       712/1385
(51 %)
12 diff
(99.2 %id)
TI_1948087710   .a 3415 to 4125 140 to 850       711/1416
(50 %)
14 diff
(99.1 %id)
TI_1948087881   .a 3415 to 4125 136 to 846       711/1335
(53 %)
11 diff
(99.2 %id)
TI_1948088057   .a 3415 to 4125 125 to 835       711/1376
(51 %)
14 diff
(99.0 %id)
CV030329 mixed .a 3416 to 4038 1 to 623       623/623
(100 %)
0 diff
(100 %id)
BF749661 breast_normal .a 4335 to 4477 16 to 158       143/159
(89 %)
5 diff
(96.9 %id)
AA092867   .a 4350 to 4538 1 to 193       193/193
(100 %)
15 diff
(92.3 %id)
BE927834 colon .a 4441 to 4976 16 to 552       537/564
(95 %)
8 diff
(98.6 %id)
BE927938 colon .a 4450 to 5004 566 to 9       558/566
(98 %)
2 diff
(99.7 %id)
BQ378176 uterus_tumor .a 4470 to 4971 1 to 502       502/502
(100 %)
10 diff
(98.1 %id)
BC073933 Lung, Spleen, fetal, pooled .a 4615 to 5354 745 to 1   available from MGC, Submitted on the opposite strand 745/746
(99 %)
6 diff
(99.2 %id)
AA749358 germinal center B cell .a 4626 to 5045 1 to 420     Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
BI767859 pooled lung and spleen .a 4626 to 5354 729 to 1   available from MGC, Submitted on the opposite strand 729/753
(96 %)
2 diff
(99.8 %id)
TI_57183949   .a 4626 to 5354 764 to 36     Submitted on the opposite strand 729/890
(81 %)
0 diff
(100 %id)
AW592468 pooled .a 4631 to 5192 1 to 562     Submitted on the opposite strand 562/567
(99 %)
7 diff
(98.8 %id)
AW663888 pooled .a 4635 to 5203 1 to 569     Submitted on the opposite strand 569/569
(100 %)
1 diff
(99.9 %id)
AA281616 germinal center B cell .a 4636 to 5098 1 to 463     Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
BM463334 embryonal carcinoma, cell line, testis .a 4637 to 5117 1 to 483       483/1020
(47 %)
21 diff
(98.0 %id)
AI972283 Prostate .a 4640 to 4945 1 to 306     Submitted on the opposite strand 306/306
(100 %)
7 diff
(97.8 %id)
AA904494 pooled .a 4665 to 5062 1 to 398     Submitted on the opposite strand 398/398
(100 %)
0 diff
(100 %id)
BI059170 placenta_normal .a 4764 to 5018 14 to 266       253/266
(95 %)
6 diff
(97.8 %id)
AA281672 germinal center B cell .a 5081 to 5447 367 to 1     Submitted on the opposite strand 367/368
(99 %)
1 diff
(99.8 %id)
TI_1948087544   .a 5116 to 6076 1066 to 90       977/1336
(73 %)
0 diff
(100 %id)
BF056690 breast, lobullar carcinoma in situ .a 5122 to 5446 40 to 364       325/375
(86 %)
2 diff
(99.5 %id)
TI_1948087882   .a 5214 to 6076 956 to 84       873/1402
(62 %)
0 diff
(100 %id)
BG758717 B-cells, primary B-cells from tonsils (cell line) .a 5223 to 5808 587 to 2     Submitted on the opposite strand 586/589
(99 %)
0 diff
(100 %id)
TI_1948088058   .a 5315 to 6076 882 to 120       763/1464
(52 %)
0 diff
(100 %id)
T80764.
matches multiple genes
liver and spleen .a 5481 to 5575 1 to 94     also hits gene roypuby 94/94
(100 %)
2 diff
(97.9 %id)
BF950518 nervous_normal .a 5580 to 6092 1 to 513       513/514
(99 %)
21 diff
(96.0 %id)
BQ319120 colon .a 5649 to 5895 260 to 10       251/260
(96 %)
0 diff
(100 %id)
BQ365099 placenta_normal .a 5771 to 6237 493 to 25       469/493
(95 %)
0 diff
(100 %id)
AA632263 breast .a 5947 to 6319 373 to 1       373/375
(99 %)
0 diff
(100 %id)
T80427 liver and spleen .a 5977 to 6317 351 to 6       346/351
(98 %)
0 diff
(100 %id)
BQ309214 breast .a 5984 to 6123 1 to 139       139/139
(100 %)
9 diff
(93.6 %id)
BF924448 nervous_tumor .a 6427 to 6773 347 to 1     Submitted on the opposite strand 347/347
(100 %)
0 diff
(100 %id)
DW460802 Liver .a 7141 to 7261 12 to 134       123/134
(91 %)
6 diff
(95.6 %id)
BY795721 eye .a 7192 to 7290 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BF876037 lung_tumor .a 7380 to 7804 1 to 425       425/425
(100 %)
6 diff
(98.6 %id)
BQ323681 colon_ins .a 7397 to 7792 1 to 394       394/394
(100 %)
3 diff
(99.3 %id)
BF800737 colon_ins .a 7398 to 7668 22 to 291       270/291
(92 %)
6 diff
(98.0 %id)
BF877055 lung_tumor .a 7403 to 7737 1 to 335       335/335
(100 %)
8 diff
(97.7 %id)
CU447377 epidermis .a 7522 to 8248 6 to 732       727/737
(98 %)
9 diff
(98.8 %id)
BI002971 head_normal .a 7647 to 8160 531 to 14       518/535
(96 %)
0 diff
(100 %id)
DW424032 Liver .a 7686 to 7959 17 to 290       274/290
(94 %)
6 diff
(98.0 %id)
BF773411 epid_tumor .a 7762 to 8118 365 to 1     Submitted on the opposite strand 365/365
(100 %)
17 diff
(95.4 %id)
BQ361158 ovary .a 7767 to 8191 433 to 7       427/433
(98 %)
0 diff
(100 %id)
CN364876 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 7767 to 8455 1 to 688       688/689
(99 %)
2 diff
(99.8 %id)
BQ318780 colon .a 7776 to 7938 166 to 5       162/178
(91 %)
0 diff
(100 %id)
BF924559 nervous_tumor .a 8035 to 8210 210 to 35     Submitted on the opposite strand 176/210
(83 %)
0 diff
(100 %id)
AW607210 head_neck .a 8306 to 8503 195 to 3       193/198
(97 %)
0 diff
(100 %id)
BE164334 head_neck .a 8310 to 8504 14 to 207       194/207
(93 %)
6 diff
(97.2 %id)
AW607383 head_neck .a 8333 to 8504 9 to 179       171/179
(95 %)
6 diff
(96.7 %id)
AA757589 pineal gland .a 8448 to 8917 496 to 27   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 470/496
(94 %)
0 diff
(100 %id)
CN364875 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 8697 to 9369 1 to 672       672/672
(100 %)
3 diff
(99.6 %id)
CN364877 embryonic stem cells, cell lines H1, H7, andH9 .a 9099 to 9808 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
EC444326 Prostate .a 9505 to 9597 1 to 91       91/91
(100 %)
6 diff
(93.5 %id)
BF088577 head_neck .a 9651 to 9883 11 to 240       230/246
(93 %)
4 diff
(98.4 %id)
BQ367799 placenta_normal .a 9862 to 10272 1 to 416       416/416
(100 %)
21 diff
(95.0 %id)
BF734457 amnion_normal .a 10038 to 10285 12 to 261       250/277
(90 %)
11 diff
(96.1 %id)
AW246179 lung, small cell carcinoma .a 10048 to 10444 9 to 405       397/405
(98 %)
1 diff
(99.8 %id)
BE265432 lung, small cell carcinoma .a 10067 to 10717 1 to 666       644/667
(96 %)
13 diff
(98.1 %id)
BQ228893 embryonal carcinoma, cell line, testis .a 10080 to 11054 1 to 990       990/1081
(91 %)
49 diff
(95.5 %id)
EC441344 Prostate .a 10149 to 10258 1 to 109       109/109
(100 %)
3 diff
(97.3 %id)
BI260189 cervical carcinoma cell line, cervix .a 10159 to 10781 1 to 648       648/656
(98 %)
48 diff
(92.7 %id)
EC584675 Prostate .a 10190 to 10280 1 to 87       87/87
(100 %)
4 diff
(95.5 %id)
CF136836 lymph .a 10418 to 10924 1 to 507       507/507
(100 %)
6 diff
(98.9 %id)
TI_154166114   .a 10424 to 11174 79 to 827       749/753
(99 %)
23 diff
(97.0 %id)
AL135615 melanoma (MeWo cell line) .a 10473 to 10974 1 to 502       502/502
(100 %)
0 diff
(100 %id)
BF765977 colon_est .a 10498 to 10813 316 to 2     Submitted on the opposite strand 315/401
(78 %)
0 diff
(100 %id)
BM724022 eye, fetal eye .a 10622 to 10991 1 to 373       373/373
(100 %)
5 diff
(98.7 %id)
BG165063 hypernephroma, cell line, Kidney .a 10683 to 11243 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
BF724909 eye, Iris .a 10719 to 11183 1 to 465       465/465
(100 %)
0 diff
(100 %id)
BM454482 embryonal carcinoma, cell line, testis .a 10721 to 11229 1 to 510       510/1065
(47 %)
3 diff
(99.8 %id)
BQ877246 ductal carcinoma, cell line, Pancreas .a 10739 to 11236 1 to 498       498/991
(50 %)
1 diff
(99.9 %id)
BQ222597 leiomyosarcoma, uterus .a 11052 to 11633 1 to 582       582/1167
(49 %)
27 diff
(97.7 %id)
BQ639252 eye, retina .a 11064 to 11658 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BQ671291 epidermoid carcinoma, cell line, salivary gland .a 11197 to 11751 1 to 549       549/1031
(53 %)
24 diff
(97.7 %id)
BE792960 lung, small cell carcinoma .a 11224 to 11463 81 to 320       240/322
(74 %)
1 diff
(99.7 %id)
AI738776 colon, colon tumor, RER+ .a 11250 to 11891 642 to 1       642/642
(100 %)
14 diff
(97.9 %id)
BM930871 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 11302 to 11885 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BM930111 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 11383 to 11894 1 to 512   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 512/512
(100 %)
0 diff
(100 %id)
AI086404 anaplastic oligodendroglioma, brain .a 11441 to 11897 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AW674176   .a 11443 to 11885 474 to 32   AAA Possibly primed on the genome, locally A rich (36/39 A in genome downstream of last aligned base) 443/466
(95 %)
15 diff
(96.8 %id)
BU742062 eye, fetal eye .a 11446 to 11903 458 to 1       458/458
(100 %)
4 diff
(99.2 %id)
AI142451 uterus .a 11471 to 11895 425 to 1       425/443
(95 %)
6 diff
(98.7 %id)
TI_149290121   .a 11492 to 11913 481 to 61       421/506
(83 %)
0 diff
(100 %id)
AA888962   .a 11512 to 11897 384 to 1       384/386
(99 %)
6 diff
(98.5 %id)
BM973237 lung .a 11532 to 11904 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
CA421396 Bone, Enchondroma cell line .a 11539 to 11909 372 to 2       371/373
(99 %)
0 diff
(100 %id)
AW118098 pooled .a 11545 to 11899 355 to 1       355/355
(100 %)
1 diff
(99.8 %id)
AW589386 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 11549 to 11999 453 to 1       453/453
(100 %)
8 diff
(98.3 %id)
AA547936 germ cell tumor .a 11570 to 11896 328 to 2       327/391
(83 %)
0 diff
(100 %id)
BU960198 mixed (pool of 40 RNAs) .a 11602 to 11909 1 to 311       311/320
(97 %)
4 diff
(98.8 %id)
CD678593 eye, Trabecular meshwork .a 11641 to 11892 1 to 252   AAA Possibly primed on the genome, locally A rich (30/32 A in genome downstream of last aligned base) 252/252
(100 %)
0 diff
(100 %id)
BI062632 uterus_tumor .a 11648 to 12056 1 to 408       408/408
(100 %)
3 diff
(99.3 %id)
BI063209 uterus_tumor .a 11648 to 12056 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
BM684742 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 11671 to 11903 233 to 1   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 233/233
(100 %)
0 diff
(100 %id)
C02430   .a 11672 to 11885 1 to 214       214/214
(100 %)
2 diff
(99.1 %id)
CB991934 placenta, pre-eclamptic placenta .a 11712 to 12498 20 to 808   tiling clone,   789/808
(97 %)
10 diff
(98.8 %id)
CK128767 embryonic stem cell, Embryonic stem cells pooled from H7 ES cellline, passage 22 .a 11755 to 12484 16 to 740   tiling clone,   725/742
(97 %)
4 diff
(99.5 %id)
FN151008 breast carcinoma .a 11790 to 11877 1 to 88       88/88
(100 %)
2 diff
(97.8 %id)
AW249907 lung, small cell carcinoma .a 11851 to 11902 52 to 1       52/52
(100 %)
1 diff
(98.1 %id)
CN291305 embryonic stem cells, DMSO-treated H9 cellline .a 11929 to 12339 1 to 411       411/411
(100 %)
1 diff
(99.8 %id)
AI698092 carcinoid, lung .a 12141 to 12691 548 to 1   tiling clone,   548/548
(100 %)
2 diff
(99.7 %id)
AA081806   .a 12220 to 12471 1 to 253       253/253
(100 %)
3 diff
(98.9 %id)
BY799288 eye .a 12416 to 12519 1 to 104       104/106
(98 %)
2 diff
(98.2 %id)
BX498567 Liver .a 12488 to 13003 1 to 513       513/513
(100 %)
8 diff
(98.5 %id)
BC043190 Brain, hypothalamus .a 12491 to 15743 1 to 3253   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 3253/3253
(100 %)
10 diff
(99.7 %id)
DB504373 hypothalamus .a 12496 to 12974 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
CN276958 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 12548 to 12696 1 to 149       149/149
(100 %)
0 diff
(100 %id)
BX478785   .a 12645 to 13107 8 to 470   tiling clone,   463/470
(98 %)
6 diff
(98.8 %id)
AA740405 2 pooled tumors (clear cell type), Kidney .a 12691 to 13052 364 to 1       364/364
(100 %)
2 diff
(99.5 %id)
AI377263 pooled .a 12849 to 13305 453 to 1       453/453
(100 %)
2 diff
(99.6 %id)
BG117299 adenocarcinoma, cell line, Liver .a 12851 to 13550 1 to 697       697/946
(73 %)
17 diff
(98.3 %id)
AA332578 Embryo, 8 weeks .a 12908 to 13182 1 to 277       277/277
(100 %)
2 diff
(99.3 %id)
AA972824 pooled .a 12909 to 13305 393 to 1       393/393
(100 %)
2 diff
(99.5 %id)
FN156354 breast carcinoma .a 12942 to 13030 92 to 4     Submitted on the opposite strand 89/92
(96 %)
0 diff
(100 %id)
DA550737.
matches multiple genes
  .a 12967 to 13401 2 to 437   capped also hits gene SLC7A14 436/436
(100 %)
1 diff
(99.8 %id)
CD000604 Pooled-Skin .a 13028 to 13702 1 to 682   tiling clone,   682/735
(92 %)
13 diff
(98.3 %id)
AI298994 carcinoid, lung .a 13049 to 13466 1 to 414     Submitted on the opposite strand 414/414
(100 %)
2 diff
(99.6 %id)
AI417673 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 13234 to 13706 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AW470262 carcinoid, lung .a 13244 to 13705 467 to 1       467/467
(100 %)
5 diff
(99.0 %id)
CD244857 White Matter .a 13259 to 14071 21 to 847       827/968
(85 %)
22 diff
(97.8 %id)
CD245175 White Matter .a 13264 to 14088 1 to 834       834/876
(95 %)
22 diff
(97.5 %id)
R77569 placenta .a 13272 to 13606 1 to 344       344/401
(85 %)
13 diff
(96.8 %id)
BM557333 melanotic melanoma, skin .a 13294 to 14084 1 to 798       798/1084
(73 %)
7 diff
(99.4 %id)
AI700540 carcinoid, lung .a 13409 to 13705 297 to 1       297/302
(98 %)
0 diff
(100 %id)
BE890480 melanotic melanoma, skin .a 13442 to 14108 1 to 671       671/671
(100 %)
13 diff
(98.1 %id)
AI351405   .a 13455 to 13705 251 to 1       251/251
(100 %)
0 diff
(100 %id)
CN358489 embryonic stem cells, DMSO-treated H9 cellline .a 13456 to 14222 1 to 767       767/767
(100 %)
1 diff
(99.9 %id)
N26052 melanocyte .a 13497 to 13704 209 to 1       209/209
(100 %)
2 diff
(99.1 %id)
DB162507 thymus .a 13500 to 14086 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BX501753 Liver .a 13501 to 14130 1 to 628       628/628
(100 %)
1 diff
(99.9 %id)
BX501766 Liver .a 13501 to 13665 1 to 165       165/165
(100 %)
0 diff
(100 %id)
FN119283 breast carcinoma .a 13513 to 13590 78 to 1     Submitted on the opposite strand 78/80
(97 %)
0 diff
(100 %id)
AV716771   .a 13528 to 14004 21 to 497   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 477/497
(95 %)
8 diff
(98.4 %id)
AA018898 eye, retina .a 13630 to 13952 1 to 323       323/323
(100 %)
2 diff
(99.4 %id)
BQ368723 placenta_normal .a 13657 to 13855 201 to 3       199/216
(92 %)
0 diff
(100 %id)
BQ371007 prostate_normal .a 13811 to 14095 291 to 7       285/291
(97 %)
0 diff
(100 %id)
BQ371008 prostate_normal .a 13811 to 14095 286 to 4       283/286
(98 %)
0 diff
(100 %id)
T27474   .a 13957 to 14144 1 to 188       188/188
(100 %)
0 diff
(100 %id)
CA396404 eye, RPE/choroid .a 13996 to 14530 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
BQ330073 lung_tumor .a 14052 to 14217 1 to 167       167/177
(94 %)
9 diff
(95.0 %id)
DA382563 thalamus .a 14058 to 14681 2 to 625   tiling clone, capped   624/624
(100 %)
0 diff
(100 %id)
BQ932523 sciatic nerve .a 14185 to 14661 1 to 484       484/1094
(44 %)
36 diff
(96.8 %id)
DA706479   .a 14199 to 14755 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
BG530006 embryonal carcinoma, testis .a 14209 to 14971 1 to 763       763/766
(99 %)
22 diff
(97.2 %id)
BG502326 embryonal carcinoma, testis .a 14233 to 14925 1 to 695       695/906
(76 %)
17 diff
(98.2 %id)
AA219097   .a 14239 to 14643 1 to 413       413/419
(98 %)
14 diff
(96.7 %id)
BM457011 embryonal carcinoma, cell line, testis .a 14378 to 15310 13 to 962       950/1067
(89 %)
6 diff
(99.5 %id)
BG611064 adenocarcinoma, Prostate .a 14475 to 15201 1 to 730       730/733
(99 %)
29 diff
(96.1 %id)
AW834788 leiomios .a 14564 to 14699 149 to 13       137/149
(91 %)
0 diff
(100 %id)
BF247602 hypernephroma, Kidney .a 14567 to 15277 1 to 710       710/769
(92 %)
52 diff
(93.3 %id)
BQ718896 sympathetic trunk .a 14660 to 15170 1 to 511   tiling clone,   511/992
(51 %)
1 diff
(99.9 %id)
TI_159691464   .a 14665 to 15692 70 to 1085     Submitted on the opposite strand 1016/1169
(86 %)
26 diff
(97.8 %id)
AL039607 testis .a 14697 to 15171 475 to 1     Submitted on the opposite strand 475/475
(100 %)
1 diff
(99.8 %id)
DN913066   .a 14730 to 15392 15 to 670       656/694
(94 %)
16 diff
(97.7 %id)
DN915796   .a 14738 to 15260 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
TI_149287116   .a 14820 to 15777 1008 to 59       950/1204
(78 %)
0 diff
(100 %id)
BM721090 eye, fetal eye .a 14856 to 15533 1 to 678   fully sequenced,   678/678
(100 %)
0 diff
(100 %id)
BG503633 embryonal carcinoma, testis .a 14900 to 15612 1 to 712       712/713
(99 %)
9 diff
(98.8 %id)
BE766333 nervous_tumor .a 14964 to 15209 1 to 247       247/250
(98 %)
5 diff
(98.0 %id)
BQ343648 nervous_tumor .a 14966 to 15102 11 to 147       137/147
(93 %)
6 diff
(96.0 %id)
BE765647 nervous_tumor .a 14971 to 15322 371 to 20       352/371
(94 %)
0 diff
(100 %id)
BE765748 nervous_tumor .a 14971 to 15318 1 to 348       348/348
(100 %)
0 diff
(100 %id)
BE769163 prostate_tumor .a 14971 to 15318 370 to 24       347/370
(93 %)
0 diff
(100 %id)
BE769181 prostate_tumor .a 14971 to 15284 1 to 314       314/314
(100 %)
2 diff
(99.4 %id)
BE765790 nervous_tumor .a 14979 to 15209 1 to 231       231/231
(100 %)
0 diff
(100 %id)
BE766478 nervous_tumor .a 15001 to 15322 327 to 5       323/327
(98 %)
0 diff
(100 %id)
BM972409 lung .a 15066 to 15743 695 to 17   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 679/679
(100 %)
6 diff
(99.2 %id)
AA450188   .a 15093 to 15528 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
BX098207   .a 15094 to 15564 1 to 471       471/471
(100 %)
2 diff
(99.6 %id)
DA570950 whole embryo, mainly head .a 15096 to 15596 2 to 501   fully sequenced, capped   500/500
(100 %)
2 diff
(99.6 %id)
BM931406 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 15118 to 15547 1 to 430   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
BM719744 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 15118 to 15547 1 to 430   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
FN095227 breast carcinoma .a 15140 to 15228 1 to 90       90/91
(98 %)
4 diff
(95.7 %id)
BE769153 prostate_tumor .a 15172 to 15297 131 to 2       130/131
(99 %)
10 diff
(92.4 %id)
BG954731 colon .a 15187 to 15577 1 to 393       393/393
(100 %)
8 diff
(98.0 %id)
AI702966 carcinoid, lung .a 15219 to 15742 524 to 1       524/531
(98 %)
1 diff
(99.9 %id)
DB575615 hypothalamus .a 15252 to 15743 1 to 492     Submitted on the opposite strand 492/492
(100 %)
0 diff
(100 %id)
N35433 melanocyte .a 15257 to 15620 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
BE929956 placenta_normal .a 15269 to 15584 1 to 323       323/323
(100 %)
17 diff
(94.8 %id)
DN913067   .a 15306 to 15925 623 to 1       623/623
(100 %)
3 diff
(99.6 %id)
BF207818 bladder, carcinoma, cell line .a 15312 to 15953 1 to 635       635/636
(99 %)
24 diff
(96.3 %id)
AI216188 carcinoid, lung .a 15338 to 15742 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
AW085297 pooled .a 15350 to 15746 400 to 1       400/400
(100 %)
4 diff
(99.0 %id)
AI304888 carcinoid, lung .a 15370 to 15738 1 to 369     Submitted on the opposite strand 369/369
(100 %)
0 diff
(100 %id)
BX503734.
matches multiple genes
  .a 15374 to 16063 690 to 1     also hits gene LSG1 690/690
(100 %)
1 diff
(99.9 %id)
BQ007785 Chondrosarcoma, Left Pelvis .a 15376 to 16054 703 to 25   AAA   679/685
(99 %)
0 diff
(100 %id)
BX501754 Liver .a 15404 to 16031 628 to 1       628/628
(100 %)
2 diff
(99.7 %id)
DN915797   .a 15455 to 16060 605 to 1       605/605
(100 %)
0 diff
(100 %id)
AW004705 colon .a 15498 to 15919 444 to 23   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 422/422
(100 %)
3 diff
(99.3 %id)
BM679522 eye, fetal eye .a 15510 to 16054 570 to 25   fully sequenced, AAA   546/552
(98 %)
0 diff
(100 %id)
BQ216333 embryonal carcinoma, cell line, testis .a 15526 to 16060 1 to 533       533/1020
(52 %)
2 diff
(99.9 %id)
BG256943 embryonal carcinoma, cell line, testis .a 15528 to 16053 32 to 560       529/569
(92 %)
16 diff
(97.2 %id)
AW976007   .a 15529 to 16064 656 to 120     Submitted on the opposite strand 537/656
(81 %)
0 diff
(100 %id)
AI288759 carcinoid, lung .a 15532 to 16063 532 to 1       532/532
(100 %)
0 diff
(100 %id)
DB357763 whole embryo, mainly head .a 15566 to 16060 490 to 1   fully sequenced,   490/490
(100 %)
0 diff
(100 %id)
H97573 melanocyte .a 15570 to 16062 497 to 1       497/497
(100 %)
12 diff
(97.6 %id)
H88485 cochlea, ear .a 15581 to 15736 1 to 157       157/157
(100 %)
1 diff
(99.4 %id)
AI288766 carcinoid, lung .a 15604 to 16060 468 to 12   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
AI362022 brain, glioblastoma (pooled) .a 15606 to 16060 476 to 22   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 455/455
(100 %)
9 diff
(98.1 %id)
AI382052 pooled .a 15606 to 16060 474 to 20   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 455/455
(100 %)
9 diff
(98.1 %id)
AI146971 uterus .a 15608 to 16042 435 to 1       435/435
(100 %)
5 diff
(98.9 %id)
BM677754 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 15621 to 16060 1 to 440   AAA Submitted on the opposite strand 440/440
(100 %)
4 diff
(99.1 %id)
BM678080 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 15621 to 16060 1 to 440   AAA Submitted on the opposite strand 440/440
(100 %)
4 diff
(99.1 %id)
AA747232 Ewing's sarcoma .a 15623 to 16064 445 to 4       442/445
(99 %)
0 diff
(100 %id)
AW875785 pnet .a 15626 to 15954 1 to 329       329/329
(100 %)
2 diff
(99.4 %id)
AW875724 pnet .a 15627 to 15954 1 to 328       328/328
(100 %)
2 diff
(99.4 %id)
BX101637 carcinoid, lung .a 15629 to 16014 1 to 386     Submitted on the opposite strand 386/386
(100 %)
1 diff
(99.8 %id)
BM725597 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 15642 to 16064 458 to 36     Submitted on the opposite strand 423/458
(92 %)
0 diff
(100 %id)
AI361923 brain, glioblastoma (pooled) .a 15647 to 16060 442 to 29   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 414/414
(100 %)
16 diff
(96.2 %id)
AI147290 brain, glioblastoma (pooled) .a 15649 to 16060 441 to 30   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 412/412
(100 %)
12 diff
(97.1 %id)
AI368135   .a 15650 to 16064 419 to 4       416/419
(99 %)
0 diff
(100 %id)
AI446314 adenocarcinoma, Pancreas .a 15654 to 16064 417 to 6       412/462
(89 %)
0 diff
(100 %id)
AA450122   .a 15664 to 16060 398 to 1       398/398
(100 %)
2 diff
(99.5 %id)
BM725321 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 15668 to 16064 432 to 36   tiling clone, Submitted on the opposite strand 397/432
(91 %)
0 diff
(100 %id)
AI620789 Prostate .a 15683 to 16064 386 to 5       382/386
(98 %)
0 diff
(100 %id)
BF092934 testis_normal .a 15732 to 15919 191 to 4       188/197
(95 %)
0 diff
(100 %id)
CD104446 Pooled-Skin .a 15738 to 16000 1 to 263   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 263/263
(100 %)
2 diff
(99.3 %id)
AI359256 brain, glioblastoma (pooled) .a 15745 to 16060 357 to 42   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 316/316
(100 %)
19 diff
(94.0 %id)
AA741533 2 pooled tumors (clear cell type), Kidney .a 15750 to 16060 325 to 15   AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
AW149874 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 15853 to 16040 188 to 1       188/188
(100 %)
3 diff
(98.5 %id)
N66403 cochlea, ear .a 15855 to 16042 188 to 1       188/188
(100 %)
0 diff
(100 %id)
AW515145 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 15901 to 16060 161 to 1       161/161
(100 %)
1 diff
(99.4 %id)
H88486 cochlea, ear .a 15908 to 16046 139 to 1       139/139
(100 %)
0 diff
(100 %id)
FN150676 breast carcinoma .a 15943 to 16040 1 to 94       94/96
(97 %)
4 diff
(95.9 %id)
ES311102 scalp interfollicular dermis, skin .b 1 to 455 1 to 457 C73V A75W V76L L77S E78L ... tiling clone,   457/457
(100 %)
2 diff
(99.6 %id)
AA569057 liposarcoma .c-u 1 to 213 8 to 221 P11S A12C T13N S14L K15Q ... tiling clone,   214/221
(96 %)
6 diff
(97.3 %id)
BI003278 head_normal Gene ZFHX3, variant not shown         Suspected internal deletion, this clone was ignored    
D10250 hepatoma Gene ZFHX3, variant not shown         Suspected internal deletion, this clone was ignored    
AA179968   Gene ZFHX3, variant not shown         This clone was ignored    
AA180460   Gene ZFHX3, variant not shown         This clone was ignored    
AI000867 breast Gene ZFHX3, variant not shown         Suspected internal deletion, this clone was ignored    
BF345134 anaplastic oligodendroglioma with 1p/19qloss, brain Gene ZFHX3, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI